Notably, CD4 T cells deficient in IL-17A showed a diminished capacity to induce GVHD; this reduction was correlated with lower levels of IFN-γ production by CD4 T cells, macrophages, and granulocytes during the early phase post BMT [174]. Here, IL17A is linked to graft versus host disease.